Log in
Login
Password
Remember
Lost password
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nyse  >  Johnson & Johnson    JNJ

SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector news 
The feature you requested does not exist. However, we suggest the following feature:

Health Care Stocks Down on Biosimilar Fears - Health Care Roundup

02/05/2016 | 04:27pm US/Eastern

The health-care sector fell amid concerns a new wave of generic drugs could compete with newer biotechnology-based products. Shares of AbbVie and Johnson & Johnson fell after U.S. Food and Drug Administration documents hinted a cheaper competitor for the drug companies' blockbuster anti-inflammatory treatments from a Korean company could be headed to market soon. SciClone Pharmaceuticals rose after the maker of a Hepatitis B treatment said it was reviewing strategic alternatives, having settled a U.S. Securities and Exchange Commission investigation into its China operations.

-By Rob Curran, rob.curran@dowjones.com

React to this article
Latest news on JOHNSON & JOHNSON
02/05DJHealth Care Stocks Down on Biosimilar Fears - Health Care Roundup
02/05DJJ&J, AbbVie Shares Drop on Potential Drug Competition
02/05DJJ&J, AbbVie Shares Drop on Potential Drug Competition
02/05 DOW MOVERS : Jnj, wmt
02/04 JOHNSON & JOHNSON : The Seasons Performance Hall in Yakima ousts executive direc..
02/04 JOHNSON & JOHNSON : Universal McCann named Agency of the year 2016
02/04 JOHNSON & JOHNSON : C2 Therapeutics Announces Leadership Team Expansion
02/04 JOHNSON & JOHNSON : Reports 2015 Fourth-Quarter Results:
02/04 JOHNSON & JOHNSON : Reports Outline Pain Management Findings from Johnson & John..
02/04 JOHNSON & JOHNSON : Possible diabetes cure is being tested
Advertisement
News chart
Full-screen chart
Income Statement Evolution
More Financials